SNMP yields 3590.08% · JNJ yields 2.14%● Live data
📍 SNMP pulled ahead of the other in Year 1
Combined, SNMP + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SNMP + JNJ for your $10,000?
Evolve Transition Infrastructure LP, together with its subsidiaries, engages in the acquisition, development, ownership, and operation of infrastructure for the transition of energy supply to lower carbon sources in the United States. The company engages in gathering, processing, and transporting natural gas, NGLs, and crude oil. This segment also operates approximately 160 miles of gathering pipelines, as well as four gathering and processing facilities, including stabilizers, storage tanks, compressors and dehydration units, and other related assets in Western Catarina, which are located in Dimmit and Webb Counties, Texas; and provides upstream production services from the Eagle Ford Shale in South Texas. It owns production assets in Texas and Louisiana. Evolve Transition Infrastructure GP LLC serves as the general partner of the company. The company was formerly known as Sanchez Midstream Partners LP and changed its name to Evolve Transition Infrastructure LP in February 2021. Evolve Transition Infrastructure LP was incorporated in 2005 and is based in Houston, Texas.
Full SNMP Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.